The biological activities of cinnamon, geranium and lavender essential oils

Molecules

Volumn 19, Issue 12, 2014, Pages 20929-20940

  Sienkiewicz, Monika ^a   Glowacka, Anna ^a   Kowalczyk, Edward ^a   Wiktorowska Owczarek, Anna ^a   Jóźwiak Bębenista, Marta ^a   Łysakowska, Monika ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acinetobacter sp.; Cinnamon oil; ESBL positive strains; Geranium oil; Lavender oil; Minimal inhibitory concentration

Indexed keywords

ANTIINFECTIVE AGENT; CINNAMON OIL, BARK; ESSENTIAL OIL; LAVENDER OIL; VEGETABLE OIL;

ACINETOBACTER BAUMANNII; CELL SURVIVAL; CHEMISTRY; CINNAMOMUM ZEYLANICUM; DRUG EFFECTS; GERANIUM; HUMAN; IC50; LAVENDER; MICROBIAL SENSITIVITY TEST; TUMOR CELL LINE;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CINNAMOMUM ZEYLANICUM; GERANIUM; HUMANS; INHIBITORY CONCENTRATION 50; LAVANDULA; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; PLANT OILS;

EID: 84919752767     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules191220929     Document Type: Article

References (36)

1. Maragakis, L.L.; Perl, T.M. Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options. Clin. Infect. Dis. 2008, 46, 1254-1263.
2. Fournier, P.E.; Richet, H.; Weinstein, R.A. The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities. Clin. Infect. Dis. 2006, 42, 692-699.
3. Cusri, S.; Chongsuvivatwong, V.; Riviera, J.I.; Silpapojakul, K.; McNeil, E.; Doi, Y. Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pitii. Antimicrob. Agents Chemother. 2014, 58, 4172-4179.
4. Inouye, S.; Takizawa, T.; Yamaguchi, H. Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J. Antimicrob. Chemother. 2001, 47, 565-573.
5. Inouye, S.; Yamaguchi, H.; Takizawa, T. Screening of the antibacterial effects of a variety of essential oils on respiratory tract pathogens, using a modified dilution assay method. J. Infect. Chemother. 2001, 7, 251-254.
6. Sivamani, P.; Hameed, A.S.S. In vitro antibacterial activity of essential oils of selected herbals against isolates from HIV/AIDS patients. J. Pharm. Res. 2010, 3, 672-678.
7. Prabuseenivasan, S.; Jayakumar, M.; Ignacimuthu, S. In vitro antibacterial activity of some plant essential oils. BMC Complement. Altern. Med. 2006, 6, doi:10.1186/1472-6882-6-39.
8. Cavanagh, H.MA.; Wilkinson, J.M. Lavender essential oil: A review. Aust. Infect. Control. 2005, 10, 35-37.
9. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antibacterial activity of essential oils and other plant extracts. J. Appl. Microbiol. 1999, 86, 985-990.
10. Manosroi, J.; Dhumtanom, P.; Manosroi, A. Antiproliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett. 2006, 235, 114-120.
11. Tsuneki, H.; Ma, E.L.; Kobayashi, S.; Sekizaki, N.; Maekawa, K.; Sasaoka, T.; Wang, M.W.; Kimura, I. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur. J. Pharmacol. 2005, 512, 105-115.
12. Guba, R. Toxicity myths essential oils and their carcinogenic potential. Int. J. Aromather. 2001, 11, 76-83.
13. Stammati, A.; Bonsi, P.; Zucco, F.; Moezelaar, R.; Alakomi, H.I.; von Wright, A. Toxicity of selected plant volatiles in microbial and mammalian short-term assays. Food Chem. Toxicol. 1999, 37, 813-823.
14. Lahlou, S.; Leal-Cardoso, J.; Duarte, G. Antihypertensive effects of the essential oil of Alpinia zerumbet and its main constituent, terpinen-4-ol, in DOCA-salt hypertensive conscious rats. Fundam. Clin. Pharmacol. 2003, 17, 323-330.
15. Dijoux, N.; Guingand, Y.; Bourgeois, C.; Durand, S.; Fromageot, C.; Combe, C.; Ferret, P.J. Assessment of the phototoxic hazard of some essential oils using modified 3T3 neutral red uptake assay. Toxicol. In Vitro 2006, 20, 480-489.
16. Bleasel, N.; Tate, B.; Rademaker, M. Allergic contact dermatitis following exposure to essential oils. Australas. J. Dermatol. 2002, 43, 211-213.
17. th ed.; Council of Europe: Strasbourg, France, 2008.
18. th ed.; Polish Pharmaceutical Society: Warsaw, Poland, 2008.
19. Prakasam, G.; Bhashini, M.; Lakshmipriya, N.; Ramesh, S.S. In-vitro antibacterial activity of some essential oils against clinical isolates of Acinetobacter baumannie. Indian J. Med. Microbiol. 2014, 32, 90-91.
20. Prashar, A.; Locke, I.C.; Evans, C.S. Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif. 2004, 37, 221-229.
21. Yap, P.S.X.; Yiap, B.C.; Ping, H.C.; Lim, S.H.E. Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance. Open Microbiol. J. 2014, 8, 6-14.
22. Mayaud, L.; Carricajo, A.; Zhiri, A.; Aubert, G. Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett. Appl. Microbiol. 2008, 47, 167-173.
23. Fani, M.M.; Kohanteb, J. Inhibitory activity of Cinnamon zeylanicum and Eucalyptus globulus oils on Streptococcus mutans, Staphylococcus aureus, and Candida species isolated from patients with oral infections. Shiraz Univ. Dent. J. 2011, 11, 14-22.
24. Pinto, V.; Barbosa, C.; Magalhães, P.; Coelho, C.; Fontenelle, J.; Cristino-Filho, G.; Chaves, H.; Silva, A.; Teixeira, A.; Bezerra, M. Antimicrobial activity of the trans-cinnamaldehyde on nosocomial enteric bacilli producers of extended spectrum β-lactamase (ESBL). BMC Proc. 2014, 8 (Suppl. 4), doi:10.1186/1753-6561-8-S4-P89.
25. Sienkiewicz, M.; Poznañska-Kurowska, K.; Kaszuba, A.; Kowalczyk, E. The antibacterial activity of geranium oil against Gram-negative bacteria isolated from difficult-to-heal wounds. Burns 2013, 40, 1046-1051.
26. Guerra, F.Q.; Mendez, J.M.; Sousa, J.P.; Moralis-Braga, M.F.; Santos, B.H.; Melo Coutinho, H.D.; lima Ede, O. Increasing antibiotic activity against a multidrug-resistant Acinetobacter spp by essential oils of Citrus limon and Cinnamomum zeylanicum. Nat. Prod. Res. 2012, 26, 2235-2238.
27. Khanuja, S.P.S.; Srivastava, S.; Shasney, A.K.; Darokar, M.; Kumar, T.R.S. Agarwal, K.K.; Ahmed, A.; Patra, N.K.; Sinha, P.; Dhawan, S.; et al. Formulation Comprising Thymol Useful in the Treatment of Drug Resistant Bacterial Infections. U.S. Patent 6,824,795, 30 November 2004.
28. Johnson, E.A.; Brehm-Stecher, B.F. Method of Sensitizing Microbial Cells to Antimicrobial Compound. U.S. Patent 6,319,958, 20 November 2001.
29. NIST 98.1 NIST/EPA/NIH Mass Spectral Library; Mass Spectrometry Data Center National Institute of Standards and Technology: Gaithersburg, MD, USA, 1998.
30. th ed.; John Wiley & Sons Inc.: Hoboken, NJ, USA, 2008.
31. MassFinder 3.1 Mass Spectral Library "Terpenoids and Related Constituents of Essential oils"; Hochmuth Scientific Consulting: Hamburg, Germany, 2007.
32. th ed.; Allured Publishing Corporation: Carol Stream, IL, USA, 2007.
33. Joulain, D.; Konig, W.A. The Atlas of Spectral Data of Sesquiterpene Hydrocarbons; E.B.-Verlag: Hamburg, Germany, 1998.
34. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint Tables for Interpretation of MICs and Zone Diameters, version 2.0; EUCAST Laboratory for Antimicrobial Susceptibility Testing: Växjö, Sweden, 1 January 2012. Available online: http://www.eucast.org (accessed on 16 August 2012).
35. Ades, E.W.; Candal, F.J.; Swerlick, R.A.; George, V.G.; Summers, S.; Bosse, D.C.; Lawley, T.J. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J. Investig. Dermatol. 1992, 99, 683-690.
36. Wiktorowska-Owczarek, A. The effect of diclofenac on proliferation and production of growth factors by endothelial cells (HMEC-1) under hypoxia and inflammatory conditions. Acta Pharm. 2014, 64, 131-138.